Longevity Investors

Applications open: Start-Up Innovation Catalyst at LIC 2026. 9 companies. Main agenda. Direct investor access. Apply: longevityinvestors.ch/startup-cataly… #LongevityInvestors #LIC2026

For the first time in Switzerland 🇨🇭, LIC 2026 brings @daveasprey to Gstaad this September. Founder of Bulletproof. Creator of biohacking. 🔗 longevityinvestors.ch/lic-2026

ARPA-H just put $144M behind healthspan biomarkers + faster trials — longevity’s “proof layer” is going institutional. Also in LINews: petrelintide repricing, decentralized trial ops, €8B longevity reinsurance. And our take: Aging = biological inflation (crypto × longevity): longevityinvestorsnews.ch/post/crypto-me… Full LINews: mailchi.mp/longevityinves… #LongevityInvestors #LINews

Jordan Shlain, MD is joining the speaker lineup at the Longevity Investors Conference 2026 in Gstaad. Founder & Chairman of Private Medical and a pioneer of concierge medicine, Dr. Shlain brings more than two decades of experience translating medical science into practical health strategies. #LongevityInvestors #LIC2026

Bitcoin, Tech and Crypto Meets Longevity: Capital’s Shared Bet on Time longevityinvestorsnews.ch/post/crypto-me… @Longevity_Inv

Longevity is moving into the mainstream. Swiss national TV coverage from RSI (Falò) and SRF explores the science, capital, and societal questions behind longer healthspans — featuring Marc P. Bernegger, Dr. Tobias Reichmuth, and the Longevity Investors ecosystem. Watch both features: #press" target="_blank" rel="nofollow noopener">longevityinvestors.ch/#press #LongevityInvestors

What if aging is biological inflation? Bitcoin protects value across time. Longevity science aims to protect biology across time. Now crypto capital is moving into longevity. Full article ↓ longevityinvestorsnews.ch/post/crypto-me… #LongevityInvestors #LINews

Applications for Longevity Investors Conference 2026 are now open. This September, Gstaad becomes the meeting point for capital and longevity science. First speakers confirmed: Dr. Steve Horvath Dr. @NirBarzilaiMD Prof. @Dr_Bischof Dr. Jordan Shlain Many more to follow. Apply to join: 🔗 longevityinvestors.ch/lic-2026

Prof. Evelyne Bischof joins #LIC2026. Medical Director, Sheba Longevity Department. Co-founder, Healthy Longevity Medicine Society. Now also a Longevity Investors Ambassador. Gstaad - Sept 14-17 longevityinvestors.ch/lic-2026 #LongevityInvestors

Maximon's Founding Partners Dr. Tobias Reichmuth and Marc P. Bernegger were featured in finews.com in connection with the Longevity Investors Lunch in Davos, where longevity science meets capital. Beyond attending, Tobias and Marc are also the 𝐟𝐨𝐮𝐧𝐝𝐞𝐫𝐬 𝐚𝐧𝐝 𝐡𝐨𝐬𝐭𝐬 𝐛𝐞𝐡𝐢𝐧𝐝 𝐋𝐨𝐧𝐠𝐞𝐯𝐢𝐭𝐲 𝐈𝐧𝐯𝐞𝐬𝐭𝐨𝐫𝐬 𝐚𝐧𝐝 𝐢𝐭𝐬 𝐞𝐯𝐞𝐧𝐭𝐬, convening builders, researchers and investors to advance the healthspan agenda forward, grounded in science, and focused on real-world impact. Some of the strongest themes highlighted: • 𝐔𝐥𝐭𝐫𝐚-𝐩𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐳𝐞𝐝 𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞: shifting from “average humans” to individual biology • 𝐂𝐚𝐩𝐢𝐭𝐚𝐥 𝐛𝐮𝐢𝐥𝐝𝐢𝐧𝐠 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐢𝐧𝐟𝐫𝐚𝐬𝐭𝐫𝐮𝐜𝐭𝐮𝐫𝐞: from concierge care to integrated ecosystems • 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 3.0 𝐚𝐧𝐝 𝐀𝐈-𝐞𝐧𝐚𝐛𝐥𝐞𝐝 𝐩𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐨𝐧: moving from reactive care to proactive optimisation A needed reminder to stay evidence-based, including caution around 𝐰𝐞𝐥𝐥𝐧𝐞𝐬𝐬 𝐈𝐕𝐬 and questionable supplementation Tobias and Marc also delivered the 𝐜𝐥𝐨𝐬𝐢𝐧𝐠 𝐬𝐩𝐞𝐞𝐜𝐡, reflecting on what it takes to turn frontier science into scalable healthspan outcomes. 🔗 We’ll share the article and event background links in the comments.

Dr. Nir Barzilai. Leader of the TAME trial. Pioneer in centenarian genetics. President, Academy for Health & Lifespan Research. He joins LIC 2026. Gstaad - Sept 14-17 Register your interest: longevityinvestors.ch/lic-2026 #LIC2026 #LongevityInvestors

Our Founding Partner Marc P. Bernegger sat down with GstaadLife Magazine for a thoughtful conversation about what’s changing in longevity and what should change next. What we appreciate about the interview is its focus on 𝐬𝐮𝐛𝐬𝐭𝐚𝐧𝐜𝐞 𝐨𝐯𝐞𝐫 𝐬𝐭𝐨𝐫𝐲𝐭𝐞𝐥𝐥𝐢𝐧𝐠: • 𝐑𝐢𝐠𝐨𝐮𝐫 𝐨𝐯𝐞𝐫 𝐡𝐲𝐩𝐞: longevity needs measurable outcomes, strong science, and responsible delivery and not “miracle” marketing. • 𝐅𝐫𝐨𝐦 𝐧𝐢𝐜𝐡𝐞 𝐭𝐨 𝐦𝐚𝐢𝐧𝐬𝐭𝐫𝐞𝐚𝐦: real impact comes when proven tools become accessible, affordable, and integrated into everyday healthcare. • 𝐇𝐞𝐚𝐥𝐭𝐡𝐬𝐩𝐚𝐧 𝐢𝐬 𝐭𝐡𝐞 𝐩𝐨𝐢𝐧𝐭: extending life only matters if we extend quality of life with prevention, diagnostics, and interventions that people can actually use. • 𝐀 𝐟𝐢𝐞𝐥𝐝 𝐦𝐚𝐭𝐮𝐫𝐢𝐧𝐠 𝐟𝐚𝐬𝐭: the tone is shifting toward standards, scalability, and long-term value creation, exactly where the industry needs to go. If you want a great read that cuts through the noise (and captures the spirit of the Longevity Investors Conference in Gstaad), this one is worth your time. 👇 Read it here (link in comments)

Longevity Investors Lunch 2026 featured on finews.com 🇨🇭 Longevity, capital & healthcare shaping the Davos conversation. Read more: finews.com/news/english-n… #LongevityInvestors #LIL2026

The ability to measure biological age transformed longevity science. Dr. Steve Horvath joins us in Gstaad for the Longevity Investors Conference 2026. September 14–17 Hotel Le Grand Bellevue Applications open soon. Register your interest: longevityinvestors.ch/lic-2026 #LIC2026

“You can gamble with your money and make it back. If you gamble with your health, you may not.” Dr. Jordan Shlain at #LIL2026 Watch the full session: youtu.be/Wo1z3mTRho0 #LongevityInvestor

LIC 2026 returns as a curated, application-only gathering of investors deploying across biotechnology, healthspan innovation, and translational science. Save the date. Register your interest: longevityinvestors.ch/lic-2026 #LIC2026 #LongevityInvestors